Philippe Sauvage

Senior Finance and Operations Executive | CFO | COO | Pharmaceutical and Biotechnology | Market Access | Transforms Vision to Strategic Impact at Scale

Cambridge, Massachusetts, United States

About

I have a diverse and global background in finance (CFO), marketing, and operations, with previous roles in the US, Europe, and Asia, in both the public and private sectors. With my diversity of experience, I am valued for my ability to leverage technology, talents and systems to impact businesses at scale. As a servant leader role model for core values including diversity of talent and thought, I am known for the people I attract and develop to meet the demands of the business in various cultural environments. My passion lies in driving significant systems and transformation initiatives (CRM, SAP, reorganizations, M&A). Passionate about equitable access to health care and company development and growth, I also serve as a board member on organizations that share those missions.

Experience

  • Chief Financial Officer at Nuvation Bio
    Oct 2024 - Present · 1 yr 9 mos

  • Board Member at The Dimock Center
    May 2016 - Present · 10 yrs 2 mos

    Serve as board member for an organization with a mission to heal and uplift individuals and families, that endeavors to redefine the model of a healthy community by creating equitable access to comprehensive health care and education

  • Sanofi (Full-time · 12 yrs 2 mos)
    • Global Head, Operations and Access Specialty Care
      Jun 2020 - Oct 2024 · 4 yrs 5 mos

      Led global strategic segments including commercial systems, forecasting, analytics, competitive intelligence, market research, launch readiness, multichannel strategy, and market access. Managed a global team of 300+ and served as functional lead for all in-country resources. Provided strategic direction to four Vice Presidents and five Directors. • Accelerated digital transformation with a series of initiatives including new CRM platform launched in 60 countries in under two years. • Developed multi indication immunology pricing strategy including $12B+ Dupixent.

    • Head of Commercial Strategy and Portfolio Marketing, North America Respiratory and Dermatology
      Jul 2019 - Jun 2020 · 1 yr

      Dual leadership of multimillion-dollar Dupixent franchise and Head of Digital Strategy for North America. Responsible for cross indication marketing activities including digital, media buy, pharmaceutical board reviews, and launch readiness. Provided strategic direction to five Directors • Transformed brand scale with 2% increased sales through a series of successful growth initiatives including commercial conversion, digital engagement, and media investment.

    • Chief Financial Officer North America
      May 2017 - Jun 2019 · 2 yrs 2 mos

      Oversaw financial operations as CFO for all US entities. Provided strategic direction to eight Vice Presidents.

  • Board Observer at DiCE Molecules
    Jan 2021 - Jan 2022 · 1 yr 1 mo

  • Chief economic and financial officer at AP-HP, Assistance Publique - Hôpitaux de Paris
    Dec 2009 - Aug 2012 · 2 yrs 9 mos

    APHP is the largest university hospital in Europe (100,000 employees, 7B€ revenue). Led the organization finance operation with responsibility for 220 finance professionals and 450 drug enforcement, logistics, and production employees under the Agency of Health products. Reported to the CEO and provided strategic direction to seven Vice Presidents. • Instilled aggressive financial disciplines over a three-year period to stabilize hospital debt that had previously grown at the rate of $330M YOY. Reduced operating deficit to $33M from $350M audited projection. • Raised $430M in Medium Term Notes and issued the first yen-denominated bond, optimizing cost of capital fundraising.